Elenco Studi sulla PSP: A randomized, double-blind, placebo-controlled, phase 2 study to assess the efficacy, safety, and pharmacokinetics of FNP-223 (oral formulation) to slow the disease progression of progressive supranuclear palsy (PSP) (PROSPER)
Home Protocolli Sperimentali Attivi